Phase 2 Study demonstrating the Safety and Efficacy of TAK-442 in ACS
Research type
Research Study
Full title
A Phase 2, Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes
IRAS ID
2964
Contact name
Alastair C H Pell
Contact email
Eudract number
2008-000091-24
Clinicaltrials.gov Identifier
Research summary
Not published at request of researcher
REC name
Scotland A REC
REC reference
08/MRE00/68
Date of REC Opinion
2 Dec 2008
REC opinion
Further Information Favourable Opinion